Casa
evades

Study provides new look at why rare cancer often evades treatments

Por um escritor misterioso

Descrição
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
Study provides new look at why rare cancer often evades treatments
Cancers, Free Full-Text
Study provides new look at why rare cancer often evades treatments
Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery - ScienceDirect
Study provides new look at why rare cancer often evades treatments
For a 6-year-old with cancer, a future staked on the promise of immunotherapy
Study provides new look at why rare cancer often evades treatments
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
Study provides new look at why rare cancer often evades treatments
Why Do Brain Tumors Often Return After Treatment? MSK Researchers Say Stem Cells May Be Key
Study provides new look at why rare cancer often evades treatments
Recent Advances and Emerging Trends in Cancer Biomarker Detection Technologies
Study provides new look at why rare cancer often evades treatments
Cancer: Common to Rare Types, Signs, Causes, Treatment
Study provides new look at why rare cancer often evades treatments
Squamous Cell Carcinoma (SCC) Symptoms, Stages, Risk Factors and Treatment
Study provides new look at why rare cancer often evades treatments
New high-throughput method greatly expands view of how mutations impact cells
Study provides new look at why rare cancer often evades treatments
Gene Therapy: A New Frontier in Disease-Modifying Therapies
Study provides new look at why rare cancer often evades treatments
Communicable cancer: The mounting evidence
Study provides new look at why rare cancer often evades treatments
The foundation and architecture of precision medicine in neurology and psychiatry: Trends in Neurosciences
Study provides new look at why rare cancer often evades treatments
How a clinical trial cured cancer — in some cases — WHYY
Study provides new look at why rare cancer often evades treatments
Tumors hide from the immune system with help from this protein
de por adulto (o preço varia de acordo com o tamanho do grupo)